论文部分内容阅读
目的:研究瑞格列奈+二甲双胍对初诊2型糖尿病治疗的效果。方法:对我院收治的90例患者进行临床数据分析,其中90例患者均行二甲双胍治疗,在此基础上,有45例患者行瑞格列奈+二甲双胍药物治疗,对两组患者治疗后的效果进行对比分析。结果:经过治疗后,两组患者血糖指数均较比治疗前有所缓解,且行联合药物治疗的改善程度显著优于单用药物治疗,数据对比呈现为p<0.05的差异性。对两组不良反应情况对比,呈现为p>0.05的无差异性。结论:在对初诊2型糖尿病患者进行治疗的过程中,应用瑞格列奈+二甲双胍药物治疗效果显著,这对于临床研究具有重要作用。
Objective: To study the effect of repaglinide and metformin on newly diagnosed type 2 diabetes mellitus. Methods: 90 patients admitted to our hospital clinical data analysis, of which 90 patients were treated with metformin, on this basis, 45 patients treated with repaglinide + metformin, two groups of patients after treatment The effect of comparative analysis. Results: After treatment, the glycemic index of both groups was relieved before treatment, and the improvement of combination therapy was significantly better than that of single drug treatment. The data showed p <0.05 difference. Comparison of adverse reactions between the two groups, showed no difference p> 0.05. CONCLUSIONS: In the treatment of newly diagnosed type 2 diabetic patients, the application of repaglinide + metformin has significant therapeutic effect, which plays an important role in clinical research.